Ag-Finasteride 5 mg (Finasteride TABLET) 5 MG

AG-FINASTERIDE 5 MG tablets contain finasteride, a medication used to treat benign prostatic hyperplasia (BPH) and male pattern hair loss. This oral tablet is manufactured by Angita Pharma Inc. in Canada.

Strength

5 MG

Manufacturer / TM Owner

ANGITA PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

AG-FINASTERIDE 5 MG tablets are commonly used to manage symptoms associated with an enlarged prostate, such as frequent urination and difficulty urinating. Additionally, finasteride is used to treat male pattern hair loss by reducing the hormone that shrinks hair follicles. This medication is often prescribed to improve urinary flow and reduce hair loss in men.

Side Effects

Common effects of AG-FINASTERIDE 5 MG tablets may include a reduction in prostate size, leading to improved urinary symptoms. For hair loss, users may notice a slower rate of hair loss and, in some cases, regrowth. It is important to note that individual results may vary.

Precautions & Warnings

AG-FINASTERIDE 5 MG tablets should be handled with care, especially by women and children. The tablets should be stored at room temperature and kept out of reach of children. It is advisable to consult a healthcare provider before starting this medication, particularly if you have any pre-existing medical conditions.

Avoid Interactions

AG-FINASTERIDE 5 MG tablets may interact with other medications, including those that affect liver enzymes. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be moderated while using this medication.

Frequently Asked Questions

AG-FINASTERIDE 5 MG tablets are used to treat symptoms of an enlarged prostate and male pattern hair loss.

Store AG-FINASTERIDE 5 MG tablets at room temperature, away from moisture and heat, and keep them out of reach of children.

AG-FINASTERIDE 5 MG tablets are not typically recommended for women, especially those who are pregnant or may become pregnant.

Common side effects may include reduced sexual desire, erectile dysfunction, and breast enlargement in men.

The time it takes for AG-FINASTERIDE 5 MG to show effects can vary. Some users may notice improvements in urinary symptoms within a few weeks, while hair regrowth may take several months.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.